- Latest week
- 17 Jul 2026
- Close
- 2278.389893
- Fair value
- 1925.518841
- Next-week expectancy
- Negative 41.21%
MRK Chart Pack
Merck & Co., Inc.
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, MRK rose 18.47%, moving from 1,923.23 to 2,278.39. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 19.20 and has improved across the 12-week window. Market Dynamics is 0.81 on the latest week. Next-week expectancy is negative at 41.21% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 2,278.39
- 12-Week Change
- 18.47%
- Trend Signal
- Active
- Next-Week Expectancy
- Negative 41.21%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 19.20
- Market Dynamics
- 0.81
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 2,278.39
- 12-Week Change
- 18.47%
- Trend Signal
- Active
- Next-Week Expectancy
- Negative 41.21%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 19.20
- Market Dynamics
- 0.81
Over the latest 12 completed weeks ending 2026-07-17, MRK rose 18.47%, moving from 1,923.23 to 2,278.39. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 19.20 and has improved across the 12-week window. Market Dynamics is 0.81 on the latest week. Next-week expectancy is negative at 41.21% based on similar historical setup states.
Industry Peers
Mexico equities in Drug Manufacturers - General
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| BIIB Biogen Inc. | MEX | 17 Jul 2026 | 3484.00 | 3678.00 | 3484.00 | 3678.00 | 5.57% |
| GILD Gilead Sciences, Inc. | MEX | 17 Jul 2026 | 2275.00 | 2442.00 | 2275.00 | 2400.00 | 5.49% |
| PFE Pfizer Inc. | MEX | 17 Jul 2026 | 424.70 | 445.26 | 421.00 | 444.00 | 4.54% |
| ABBV AbbVie Inc. | MEX | 17 Jul 2026 | 4301.68 | 4567.00 | 4301.67 | 4495.00 | 4.49% |
| NVON Novo Nordisk A/S | MEX | 17 Jul 2026 | 864.00 | 901.00 | 851.00 | 889.66 | 2.97% |
| BMY Bristol-Myers Squibb Company | MEX | 17 Jul 2026 | 1025.00 | 1055.00 | 1000.00 | 1055.00 | 2.93% |
| LLY Eli Lilly and Company | MEX | 17 Jul 2026 | 20708.48 | 20998.51 | 19779.08 | 20736.24 | 0.13% |
| BAYNN Bayer Aktiengesellschaft | MEX | 17 Jul 2026 | 779.00 | 779.00 | 779.00 | 779.00 | 0.00% |
| GSKN GSK plc | MEX | 17 Jul 2026 | 917.00 | 917.00 | 917.00 | 917.00 | 0.00% |
| AZN1N AstraZeneca PLC | MEX | 17 Jul 2026 | 2971.00 | 2971.00 | 2947.38 | 2947.38 | -0.80% |
| NOVOBN Novo Nordisk A/S | MEX | 17 Jul 2026 | 903.49 | 939.69 | 835.00 | 894.00 | -1.05% |
| JNJ Johnson & Johnson | MEX | 17 Jul 2026 | 4503.00 | 4517.00 | 4318.81 | 4437.00 | -1.47% |
| NVSN Novartis AG | MEX | 17 Jul 2026 | 2742.00 | 2742.00 | 2696.00 | 2696.00 | -1.68% |